3′-Chloro-3′-deoxythymidine
3′-Chloro-3′-deoxythymidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Product Specifications
CAS Number
[25526-94-7]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Nucleoside Antimetabolite/Analog
Type
Oligonucleotides
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/3-chloro-3-deoxythymidine.html
Solubility
10 mM in DMSO
Smiles
Cl[C@H]1C[C@H](N2C(NC(C(C)=C2)=O)=O)O[C@@H]1CO
Molecular Formula
C10H13ClN2O4
Molecular Weight
260.67
Precautions
H302, H315, H319, H335
References & Citations
[1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18 (23) :3373-88.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
AKT2, Recombinant, Human, aa2-481, His-SUMO-Tag (RAC-beta Serine/threonine-protein Kinase)
AKT2, Recombinant, Human, aa2-481, His-SUMO-Tag (RAC-beta Serine/threonine-protein Kinase)
AKT2, Recombinant, Human, aa2-481, His-SUMO-Tag (RAC-beta Serine/threonine-protein Kinase)
